Validation study of risk prediction models for female relatives of Australian women with breast cancer

por MacInnis, R, Dite, G, Bickerstaffe, A, Dowty, J, Aujard, K, Apicella, C, Phillips, K, Weideman, P, Hopper, J
Publicado 2012

Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer

por Kiely, B. E., Friedlander, M. L., Milne, R. L., Stanhope, L., Russell, P., Jenkins, M. A., Weideman, P., McLachlan, S. A., Grant, P., Hopper, J. L., Phillips, K. A.
Publicado 2011

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre

por MacInnis, R J, Bickerstaffe, A, Apicella, C, Dite, G S, Dowty, J G, Aujard, K, Phillips, K-A, Weideman, P, Lee, A, Terry, M B, Giles, G G, Southey, M C, Antoniou, A C, Hopper, J L
Publicado 2013

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

por Phillips, KA, Milne, RL, Rookus, MA, Goldgar, D, Friedlander, M, McLachlan, SA, Buys, S, Antoniou, AC, Birch, K, Terry, MB, Easton, DF, Weideman, P, Daly, M, Andrieu, N, John, EM, Hooning, MJ, Andrulis, IL, Caldes, T, Olsson, H, Hopper, JL
Publicado 2012